As of 30 Sep 2025, 7 institutional investors reported holding 733,054 shares of NORTHWEST BIOTHERAPEUTICS INC - Stock (NWBO).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 733,054 | $175,164 | +$2,270 | $0.24 | 7 |
| 2025 Q2 | 723,604 | $173,524 | +$6,852 | $0.24 | 7 |
| 2025 Q1 | 696,814 | $160,167 | -$901 | $0.23 | 7 |
| 2024 Q4 | 712,146 | $196,441 | -$3,821 | $0.27 | 9 |
| 2024 Q3 | 655,342 | $208,709 | -$10,242 | $0.32 | 9 |
| 2024 Q2 | 669,855 | $286,210 | +$26,792 | $0.43 | 11 |
| 2024 Q1 | 587,080 | $303,577 | +$45,331 | $0.52 | 8 |
| 2023 Q4 | 521,164 | $365,079 | -$9,144 | $0.70 | 8 |
| 2023 Q3 | 529,671 | $481,940 | +$20,923 | $0.91 | 9 |
| 2023 Q2 | 2,976,111 | $1,689,679 | -$167,500 | $0.57 | 10 |
| 2023 Q1 | 3,214,516 | $2,009,124 | +$254,852 | $0.62 | 13 |
| 2022 Q4 | 2,817,706 | $2,249,392 | +$538,488 | $0.78 | 14 |
| 2022 Q3 | 953,346 | $680,062 | -$31,707 | $0.71 | 11 |
| 2022 Q2 | 1,002,870 | $633,114 | +$85,414 | $0.63 | 13 |
| 2022 Q1 | 867,691 | $602,962 | +$29,683 | $0.70 | 14 |
| 2021 Q4 | 824,457 | $576,000 | +$327,308 | $0.70 | 12 |
| 2021 Q3 | 354,257 | $453,000 | -$58,920 | $1.28 | 10 |
| 2021 Q2 | 393,657 | $577,000 | +$113,447 | $1.46 | 13 |
| 2021 Q1 | 316,480 | $472,000 | +$70,236 | $1.49 | 10 |
| 2020 Q4 | 269,242 | $409,000 | +$182,583 | $1.51 | 8 |
| 2020 Q3 | 149,062 | $114,000 | +$26,393 | $0.76 | 5 |
| 2020 Q2 | 112,000 | $38,000 | -$17,655 | $0.34 | 4 |
| 2020 Q1 | 214,503 | $34,000 | +$20,999 | $0.16 | 5 |
| 2019 Q4 | 92,500 | $20,000 | $0 | $0.21 | 4 |
| 2019 Q3 | 92,500 | $22,000 | -$29,002 | $0.24 | 4 |
| 2019 Q2 | 142,500 | $37,000 | +$2,400 | $0.26 | 4 |
| 2019 Q1 | 133,500 | $36,000 | -$5,981 | $0.26 | 4 |
| 2018 Q4 | 166,950 | $34,000 | +$9,001 | $0.20 | 6 |
| 2018 Q3 | 122,500 | $23,000 | +$2,000 | $0.19 | 4 |
| 2018 Q2 | 112,500 | $29,000 | $0 | $0.26 | 4 |
| 2018 Q1 | 112,500 | $29,000 | +$15,667 | $0.26 | 4 |
| 2017 Q4 | 52,500 | $13,000 | $0 | $0.25 | 3 |
| 2017 Q3 | 52,500 | $10,000 | +$6,000 | $0.20 | 3 |
| 2017 Q2 | 24,650 | $4,000 | $0 | $0.16 | 2 |
| 2017 Q1 | 12,150 | $2,000 | -$8,801,100 | $0.16 | 1 |
| 2016 Q4 | 25,376,730 | $8,833,000 | -$4,135,173 | $0.35 | 7 |
| 2016 Q3 | 33,367,298 | $18,113,000 | -$1,746,862 | $0.54 | 41 |
| 2016 Q2 | 36,736,624 | $21,343,000 | -$4,189,468 | $0.58 | 53 |
| 2016 Q1 | 41,993,982 | $61,311,000 | +$4,149,327 | $1.46 | 65 |
| 2015 Q4 | 38,752,463 | $123,971,091 | +$15,733,308 | $3.20 | 72 |
| 2015 Q3 | 33,669,025 | $210,462,694 | +$24,882,176 | $6.25 | 74 |
| 2015 Q2 | 28,775,393 | $285,747,053 | +$116,683,935 | $9.93 | 78 |
| 2015 Q1 | 17,517,073 | $129,085,755 | +$22,424,759 | $7.37 | 71 |
| 2014 Q4 | 14,594,118 | $78,077,182 | -$3,769,784 | $5.35 | 65 |
| 2014 Q3 | 8,642,567 | $43,461,630 | +$530,513 | $5.03 | 66 |
| 2014 Q2 | 8,400,646 | $56,345,755 | +$7,484,236 | $6.71 | 76 |
| 2014 Q1 | 7,194,924 | $52,076,344 | +$8,763,272 | $7.24 | 55 |